Logo
x

Search category

Subscribe Now

Zealand Pharma

Zealand Pharma Reports Part 1 Results of Multiple Ascending Dose Trial for ZP8396 for the Management of Overweight and Obesity

Zealand Pharma Reports Part 1 Results of Multiple Ascending Dose Trial for ZP8396 for the Management of Overweight and Obesity

  • July 3, 2023
Zealand Pharma Reports Results from P-Ia Study of ZP8396 for Patients with Obesity and Diabetes

Zealand Pharma Reports Results from P-Ia Study of ZP8396 for Patients with Obesity and Diabetes

  • March 28, 2023
Zealand Pharma Reports P-III (EASE 1) Trial Results of Glepaglutide for the Treatment of Short Bowel Syndrome

Zealand Pharma Reports P-III (EASE 1) Trial Results of Glepaglutide for the Treatment of Short Bowel Syndrome

  • September 30, 2022
Zealand Pharma Report Enrollment Completion in P-III Study of Dasiglucagon in Children with Congenital Hyperinsulinism

Zealand Pharma Report Enrollment Completion in P-III Study of Dasiglucagon in Children with Congenital Hyperinsulinism

  • February 15, 2022
PharmaShots Interview: Zealand Pharma's Dr. David Kendall Shares Insights on Zegalogue for Severe Hypoglycemia in Pediatric and Adult Patients with Diabetes

PharmaShots Interview: Zealand Pharma's Dr. David Kendall Shares Insights on Zegalogue for Severe Hypoglycemia in Pediatric and Ad...

  • September 27, 2021
PharmaShots Interview: Zealand Pharma's Emmanuel Dulac Shares Insights on Zegalogue for Severe Hypoglycemia in Pediatric and Adult Patients with Diabetes

PharmaShots Interview: Zealand Pharma's Emmanuel Dulac Shares Insights on Zegalogue for Severe Hypoglycemia in Pediatric and Adult...

  • April 28, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.